Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
NIKINiki BioSolutions, Inc.
| Figure | NIKINiki BioSolutions, Inc.FY2023 · Dec |
|---|---|
| Revenue | $431.38K |
| Revenue, yoy | −66.7% |
| Net income | $1.36M |
| Net income, yoy | +68.1% |
| Net margin | — |
| Free cash flow | $7.73M |
| FCF margin | -1,791.3% |
| EPS, diluted | $0.19 |
Add another company.
Annual · FY2021–FY2023 · USD
From SEC EDGARSame fiscal periods, as filed